SEC Form 4 · accession 0001209191-18-047490
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tim B Johnson
Officer — CEO · Director
Period of report
Aug 16, 2018
Accepted (ET)
Aug 17, 2018 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 16, 2018 | A | 75,000 | $0.00 | A | 260,509 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.40 | Aug 16, 2018 | A | 150,000 | A | — | Aug 15, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The shares vest in a series of sixteen (16) successive equal quarterly installments on the last day of each calendar quarter, commencing with the last day of the calendar quarter first occurring after August 16, 2018.